PROVECTUS BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,077 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 576-600 of 803 matching filings.

Per page
25
Current page
24
4

FORM 4

Filing date
07 Oct 2014
Reporting date
03 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2014
Reporting date
03 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2014
Reporting date
03 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
07 Oct 2014
Reporting date
07 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
29 Sep 2014
Reporting date
29 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
24 Sep 2014
Reporting date
24 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
23 Sep 2014
Reporting date
23 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
22 Sep 2014
Reporting date
22 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
18 Aug 2014
Reporting date
18 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
06 Aug 2014
Reporting date
06 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jul 2014
Reporting date
29 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jul 2014
Reporting date
29 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jul 2014
Reporting date
29 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
23 Jul 2014
Reporting date
23 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36457

CT ORDER filing

Filing date
08 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
08 Jul 2014
Reporting date
08 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jul 2014
Reporting date
28 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
19 Jun 2014
Reporting date
19 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
17 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
12 Jun 2014
Reporting date
06 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
03 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

PROVECTUS BIOPHARMACEUTICALS, INC. 8-K MAY 27, 2014

Filing date
27 May 2014
Reporting date
27 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
23 May 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
21 May 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .